|
Market Closed -
Other stock markets
|
Pre-market 21:08:09 | |||
| 93.24 USD | +3.04% |
|
93.85 | +0.65% |
| 06-25 | Major deals involving US drugmakers and biotechs over the past decade | RE |
| 06-24 | Abbott Laboratories, ALZpath Sign Global Licensing Deal for Alzheimer's Disease Diagnostic | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.04% | +5.46% | +6.67% | -11.06% | -25.58% | -32.14% | -13.71% | -17.28% | +145.95% | 162B | |
| +0.49% | +1.49% | +2.44% | -8.39% | -16.18% | -6.34% | -7.96% | -35.55% | -3.29% | 103B | |
| +0.87% | +5.56% | +4.38% | -11.73% | -15.04% | -1.84% | +52.90% | +146.65% | +280.37% | 55.83B | |
| -2.09% | -6.13% | -1.52% | -8.95% | +7.98% | +51.65% | +53.01% | +70.61% | +618.00% | 54.05B | |
| +2.44% | +5.14% | +2.54% | -4.35% | -22.00% | -11.42% | -40.99% | -37.24% | -9.20% | 41.71B | |
| +4.77% | +5.09% | +2.05% | -11.48% | -10.07% | - | - | - | - | 31.94B | |
| -1.58% | -5.27% | -4.79% | +2.71% | +3.44% | -18.93% | -45.84% | -36.19% | +254.51% | 26.49B | |
| +1.81% | +5.67% | +9.53% | +40.30% | +25.96% | +56.80% | -5.57% | -3.75% | +375.72% | 24.48B | |
| +1.66% | +3.94% | -2.76% | -5.72% | -16.93% | -12.39% | -0.10% | +1.84% | +221.82% | 20.52B | |
| +0.84% | -0.56% | -5.25% | +5.64% | -2.56% | -17.51% | -2.75% | -0.02% | +105.05% | 20.02B | |
| -1.86% | +6.31% | +1.11% | +3.92% | -17.33% | -14.82% | -23.29% | -56.87% | +203.39% | 19.61B | |
| +0.44% | +3.40% | +6.39% | +3.79% | +1.16% | -1.97% | -36.83% | -45.16% | -22.05% | 17.6B | |
| +3.08% | +3.30% | +1.42% | +20.54% | -1.67% | +3.96% | - | - | - | 13.49B | |
| +3.15% | -0.26% | +14.91% | +4.01% | +2.46% | +6.21% | +61.17% | +23.38% | +282.97% | 12.85B | |
| +2.81% | -3.50% | +7.40% | -2.53% | +12.53% | -6.11% | -46.57% | -71.43% | +122.42% | 12.58B | |
| +3.08% | +6.84% | -0.19% | -3.09% | -3.05% | +45.47% | +44.87% | +9.28% | +254.93% | 11.49B | |
| +2.42% | +8.35% | +12.36% | +25.88% | +12.77% | -29.60% | -52.15% | -73.78% | -50.86% | 11.13B | |
| +3.32% | +5.53% | -0.68% | -28.79% | -45.88% | -49.77% | -46.56% | -44.74% | +438.96% | 10.65B | |
| -2.00% | +6.86% | +8.44% | +39.96% | +23.05% | -1.12% | -5.60% | -25.99% | +117.58% | 8.66B | |
| +4.93% | +10.01% | +26.22% | +27.04% | -11.37% | +17.10% | -2.90% | -24.21% | +513.56% | 8.19B | |
| Average | +1.15% | +2.93% | +4.53% | +3.88% | -4.92% | -1.20% | -6.60% | -12.25% | +213.88% | 33.34B | |
| Weighted average by Cap. | +0.49% | +2.53% | +3.70% | -3.51% | -11.35% | -6.07% | -3.03% | -1.86% | +186.17% |
- Stock Market
- Stocks
- ABT Stock
- Sector Abbott Laboratories
Select your edition
All financial news and data tailored to specific country editions
